LogicBio Therapeutics Inc. (LOGC) NASDAQ
$2.07 - (-)
Market Cap: -
As of 11/15/22 12:00 AM EST. Market closed.
LogicBio Therapeutics Inc. (LOGC)
NASDAQ
$2.07
- (-)
Market Cap: -
As of 11/15/22 12:00 AM EST. Market closed.
LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood. The company's proprietary GeneRide™ platform is a new approach to precise gene insertion that harnesses a cell's natural DNA repair process leading to durable therapeutic protein expression levels. LogicBio's ... read more
LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood. The company's proprietary GeneRide™ platform is a new approach to precise gene insertion that harnesses a cell's natural DNA repair process leading to durable therapeutic protein expression levels. LogicBio's cutting-edge sAAVy™ capsid development platform is designed to support development of treatments in a broad range of indications and tissues. The company is based in Lexington, MA. read less
Open in: 
Open in:
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Jones Cecilia | Chief Financial Officer | Jan 12, 2022 | Option Exercise | $2.01 | 2,175 | 4,372 | 3,764 | Jan 13, 2022, 06:36 PM |
| Gruskin Daniel | Chief Medical Officer | Aug 09, 2021 | Sale | $4.35 | 1,467 | 6,381 | 3,331 | Aug 10, 2021, 06:31 PM |
| Chereau Frederic | President and Chief Executive | Apr 16, 2021 | Sale | $5.73 | 7,542 | 43,216 | 253,811 | Apr 19, 2021, 09:00 PM |
| ORBIMED ADVISORS LLC | Director | Oct 01, 2020 | Buy | $6.00 | 1,481,482 | 8,888,892 | 4,126,972 | Oct 05, 2020, 05:36 PM |
| Chimovits Erez | Director | Oct 01, 2020 | Buy | $6.00 | 1,481,482 | 8,888,892 | 4,126,972 | Oct 05, 2020, 05:32 PM |
| Arix Bioscience plc | 10% Owner | Sep 28, 2020 | Sale | $7.54 | 273,584 | 2,061,866 | 2,381,436 | Oct 05, 2020, 05:00 PM |
| Arix Bioscience plc | 10% Owner | Jul 20, 2020 | Sale | $9.25 | 36,983 | 342,056 | 2,894,607 | Oct 05, 2020, 05:00 PM |
| Arix Bioscience plc | 10% Owner | Sep 25, 2020 | Sale | $7.08 | 174,219 | 1,232,948 | 2,655,020 | Oct 05, 2020, 05:00 PM |
| Arix Bioscience plc | 10% Owner | Jul 17, 2020 | Sale | $9.24 | 31,101 | 287,373 | 2,931,590 | Oct 05, 2020, 05:00 PM |
| Arix Bioscience plc | 10% Owner | Sep 24, 2020 | Sale | $7.63 | 38,514 | 293,823 | 2,829,239 | Oct 05, 2020, 05:00 PM |
| Arix Bioscience plc | 10% Owner | Jul 16, 2020 | Sale | $8.56 | 16,332 | 139,786 | 2,962,691 | Oct 05, 2020, 05:00 PM |
| Arix Bioscience plc | 10% Owner | Aug 13, 2020 | Sale | $8.75 | 159 | 1,391 | 2,867,753 | Oct 05, 2020, 05:00 PM |
| Arix Bioscience plc | 10% Owner | Aug 12, 2020 | Sale | $8.79 | 1,335 | 11,735 | 2,867,912 | Oct 05, 2020, 05:00 PM |
| Arix Bioscience plc | 10% Owner | Jul 29, 2020 | Sale | $8.78 | 2,709 | 23,788 | 2,869,247 | Oct 05, 2020, 05:00 PM |
| Arix Bioscience plc | 10% Owner | Jul 22, 2020 | Sale | $9.00 | 22,651 | 203,950 | 2,871,956 | Oct 05, 2020, 05:00 PM |
| Wilton Thomas | Chief Business Officer | Aug 27, 2019 | Option Exercise | $0.73 | 75,000 | 54,750 | 75,000 | Aug 29, 2019, 04:15 PM |
| Arix Bioscience plc | 10% Owner | Oct 23, 2018 | Buy | $10.00 | 700,000 | 7,000,000 | 2,979,023 | Oct 26, 2018, 09:29 AM |
| ORBIMED ADVISORS LLC | Director | Oct 23, 2018 | Buy | $10.00 | 1,190,000 | 11,900,000 | 6,466,783 | Oct 25, 2018, 06:28 PM |
| Kariv Tomer | Director | Oct 23, 2018 | Buy | $10.00 | 420,000 | 4,200,000 | 1,787,413 | Oct 25, 2018, 06:27 PM |
| Ioannidou Sofia | Director | Oct 23, 2018 | Buy | $10.00 | 420,000 | 4,200,000 | 1,787,413 | Oct 25, 2018, 06:25 PM |
| O'Connell Daniel P | Director | Oct 23, 2018 | Buy | $10.00 | 700,000 | 7,000,000 | 2,979,023 | Oct 25, 2018, 06:25 PM |
| Chimovits Erez | Director | Oct 23, 2018 | Buy | $10.00 | 490,000 | 4,900,000 | 3,487,760 | Oct 25, 2018, 06:24 PM |